Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Migraine Prevention: Primary Results of the STRIVE Trial

被引：0
|
作者：
Goadsby, P. J. [1 ]
Reuter, U. [2 ]
Bonner, J. [3 ]
Broessner, G. [4 ]
Hallstrom, Y. [5 ]
Zhang, F. [6 ]
Sapra, S. [6 ]
Picard, H. [6 ]
Mikol, D. D. [6 ]
Lenz, R. A. [6 ]
机构：
[1] Kings Coll Hosp London, London, England
[2] Charite, Berlin, Brandenburg, Germany
[3] Mercy Res, St Louis, MO USA
[4] Med Univ Innsbruck, Innsbruck, Austria
[5] Stockholm Neuro Ctr, Stockholms Lan, Sweden
[6] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
HEADACHE | 2017年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IOR04
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [41] Topiramate for the prevention of paediatric migraine: a randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, S
    Jordan, D
    Fisher, A
    Hulihan, J
    CEPHALALGIA, 2004, 24 (09) : 814 - 814
  • [42] EFFICACY AND SAFETY OF ELAFIBRANOR IN PRIMARY BILIARY CHOLANGITIS: RESULTS FROM THE ELATIVE™ DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Bowlus, Christopher L.
    Kowdley, Kris V.
    Levy, Cynthia
    Akarca, Ulus
    Alvares-Da-Silva, Mario Reis
    Andreone, Pietro
    Arrese, Marco
    Corpechot, Christophe
    Francque, Sven
    Heneghan, Michael A.
    Invernizzi, Pietro
    Jones, David
    Kruger, Frederik C.
    Lawitz, Eric
    Mayo, Marlyn J.
    Shiffman, Mitchell L.
    Swain, Mark G.
    Valera, Jose Miguel
    Vargas, Victor
    Vierling, John M.
    Villamil, Alejandra
    Addy, Carol
    Dietrich, Julie
    Germain, Jean-Michel
    Mazain, Sarah
    Rafailovic, Dragutin
    Tadde, Bachirou
    Miller, Benjamin
    Shu, Jianfen
    Zein, Claudia O.
    Schattenberg, Jorn M.
    HEPATOLOGY, 2024, 79 (02) : E40 - E42
  • [43] Topiramate for migraine prevention in children: A randomized, double-blind, placebo-controlled trial
    Winner, P
    Pearlman, EM
    Linder, SL
    Jordan, DM
    Fisher, AC
    Hulihan, J
    HEADACHE, 2005, 45 (10): : 1304 - 1312
  • [44] Patient-Reported Outcomes in Chronic Migraine Patients Receiving Placebo or Erenumab (AMG 334) in a Phase 2, Randomized, Double-Blind Study
    Tepper, S.
    Lipton, R.
    Reuter, U.
    Silberstein, S.
    Stewart, W.
    Leonardi, D.
    Desai, P.
    Cheng, S.
    Mikol, D.
    Lenz, R.
    CEPHALALGIA, 2016, 36 : 45 - 46
  • [45] Patient-Reported Outcomes in Patients with Chronic Migraine Receiving Placebo or Erenumab (AMG 334) in a Phase 2, Randomized, Double-Blind Study
    Lipton, R. B.
    Tepper, S. J.
    Reuter, U.
    Silberstein, S. D.
    Stewart, W. F.
    Leonardi, D. K.
    Desai, P.
    Cheng, S.
    Mikol, D. D.
    Lenz, R. A.
    HEADACHE, 2017, 57 : 198 - 198
  • [46] Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial
    Sonbolestan, Seyed Ali
    Heshmat, Kiyan
    Javanmard, Shaghayegh Haghjooy
    Saadatnia, Mohammad
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2013, 4 (01) : 72 - 77
  • [47] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [48] A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial to Evaluate the Efficacy, Safety, and Tolerability of Prucalopride in Men With Chronic Constipation
    Yiannakou, Yan
    Piessevaux, Hubert
    Bouchoucha, Michel
    Schiefke, Ingolf
    Filip, Rafal
    Gabalec, Libor
    Dina, Ion
    Stephenson, David
    Kerstens, Rene
    Etherson, Kevin
    Levine, Amy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 (05): : 741 - 748
  • [49] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [50] A Randomized, Double-Blind, Placebo-Controlled Study of Erenumab Safety in Patients with Stable Angina
    Depre, C.
    Antalik, L.
    Starling, A. J.
    Koren, M.
    Eisele, O.
    Mikol, D.
    HEADACHE, 2018, 58 : 177 - 177
12345